Editorial :The SARS-COV2 (COVID-19) Pandemic: What Clinicians should Know

The SARS-COV2 (COVID-19) Pandemic: What Clinicians should Know

COVID-19: Virology, Pathogenesis and Potential Therapeutics

Helicobacter Pylori Treatment Eradication in Egypt: Standard Clarithromycin-based Triple versus Quadruple Regimen Therapy

IL-1α and TGF-β1 as non-Invasive Liver Fibrosis Markers of Chronic Liver Injury among Chronic Liver Diseases Patients in Sharkia Governorate, Egypt

Efficacy of Vitamin B6 Supplementation on Inflammatory Markers, Serum Homocysteine level, Fecal Calprotectin and Clinical Outcomes among Patients with Ulcerative Colitis: A Randomized Double Blind Clinical Trial

Frequency of Toxoplasmosis Among Zagazig University Students In 2017

Potential Therapeutic Effect of Allogenic Mesenchymal Stem Cells on Chronic Cerebral Murine Toxoplasmosis

The Assessment of Gastric Antral Wall Thickness in Helicobacter pylori gastritis by Abdominal Ultrasonography, Case-Control Study (2016-2018)

Therapeutic Potential of Human Umbilical Cord Blood Derived Mesenchymal Stem Cells in Murine Model of Hepatic Schistosomiasis

Efficacy of Sofosbuvir and Ledipasvir in Comparison to Sofosbuvir and Daclatasvir in Management of Egyptian Chronic Hepatitis C Patients

Cost-Effectiveness of HCV Core Antigen versus PCR for Monitoring Treatment Response in DAAS-Treated Egyptian Patients